Product Information
ORENCIA CLICKJECT 125 MG/ML is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $1471.0864 per ML under NDC 00003218851. Its NADAC has been published 450 times since Feb 21, 2018.
Strength
125 mg/mL
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003218851
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ABATACEPTApproval Type
Biologic (BLA)
FDA Application
BLA125118On Market Since
7/29/2011
Pharmacological Classes
Price Statistics
The NADAC for ORENCIA CLICKJECT 125 MG/ML has been published 450 times since Feb 21, 2018, and over the history we have for it it has risen 47.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1471.0864 per ML |
|---|---|
| All-time high | $1471.0864 (Sep 30, 2026) |
| All-time low | $996.7785 (Feb 21, 2018) |
| 52-week high | $1471.0864 |
| 52-week low | $1441.5941 |
| Median price | $1230.4995 |
| Average price | $1240.3741 |
| Largest weekly change | +6.0% (Jan 8, 2020) |
| Weeks tracked | 450 |
| Tracking since | Feb 21, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E.R. Squibb & Sons, L.L.C. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
abatacept market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ORENCIA CLICKJECT 125 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for ORENCIA CLICKJECT 125 MG/ML, manufactured by E.R. Squibb & Sons, L.L.C., is $1471.0864 per ML (NDC 00003218851), effective Sep 30, 2026.
How has the price of ORENCIA CLICKJECT 125 MG/ML changed over time?
Over the history we have for it, the NADAC for ORENCIA CLICKJECT 125 MG/ML has risen 47.6%. It has been tracked across 450 weekly CMS publications since Feb 21, 2018.
What are the highest and lowest recorded NADAC prices for ORENCIA CLICKJECT 125 MG/ML?
Since Feb 21, 2018, the NADAC for ORENCIA CLICKJECT 125 MG/ML has ranged from a low of $996.7785 (Feb 21, 2018) to a high of $1471.0864 (Sep 30, 2026), with a median of $1230.4995 per ML.
Are there cheaper alternatives to ORENCIA CLICKJECT 125 MG/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ORENCIA 125 MG/ML SYRINGE, is $1469.2280 per ML — about 0% below ORENCIA CLICKJECT 125 MG/ML.
Who manufactures ORENCIA CLICKJECT 125 MG/ML?
ORENCIA CLICKJECT 125 MG/ML (NDC 00003218851) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.